SC01009 menstrual blood-derived mesenchymal stem cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SC01009 menstrual blood-derived mesenchymal stem cell injection, covering 2025-08-20 to 2025-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]